TegoSens is developing a universally adoptable, non-invasive, and portable device that provides early actionable detection of direct lung tissue specific fluid levels in patients, driving guideline-based therapies for specific conditions such as heart failure. The TegoSens solution is extremely competitive, yet complementary to existing diagnostic offerings and addresses a significant unmet need for the management of patients at point of care and home.
Ikove makes no warranties, express or implied, regarding any of the information on this website. None of the information on this website is investment advice. This website is not a solicitation of investment or offer to purchase or sell securities.